...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: What else can RVX treat that we don’t know about yet?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Agree bfw ..... among the issues we face, and other than those related strictly to RVX corporate, company viability, BoM success ..... is simply "acceptance" within the medical community. It's new, a new frontier, we need good study results, approval, and a movement within the medical community to accept this new era ..... which then opens the door wide open for RVX-208 in Renal, Cognitive, and potentially a host of other things as other indications try it off label and push the "old school" and Ivory Tower thinking. Oh, and what about those other 3000 molecules?! ...... if RVX-208 hits, it could even dwarf the already "big picture" we have discussed in Diabetic Cardiopathy, Renal, Cognitive ... maybe?

Yes, Nasdaq, and collaborating with other BP's once RVX-208 is approved ... could be a very intersting ride for investors, and an incredible new era helping to pave the future in medicine as well.

Time will tell, JMHO and hope ...

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply